Literature DB >> 17916388

The dynamics of effector T cells and Foxp3+ regulatory T cells in the promotion and regulation of autoimmune encephalomyelitis.

Thomas Korn1, Ana C Anderson, Estelle Bettelli, Mohamed Oukka.   

Abstract

The Th1/Th2 paradigm of T helper cell subsets had to be revised when IL-17 producing T cells (Th17) were identified as a distinct T helper cell lineage. Th17 cells are very efficient inducers of tissue inflammation and crucial initiators of organ-specific autoimmunity. Whereas Th17 cells promote autoimmune tissue inflammation, Foxp3+ regulatory T cells (T-reg) are necessary and sufficient to prevent autoimmunity throughout the life span of an individual. Here, we review recent findings of how responses of effector T cells and T-reg cells with a defined antigen-specificity develop in autoimmune encephalomyelitis. Moreover, Th17 cells and Foxp3+ T-reg seem to be dichotomously related in that TGF-beta induces Foxp3 in naïve T cells, but TGF-beta and IL-6 together drive the generation of Th17 cells. Thus, we give an overview of how Th17 cells, induced Foxp3+ T-reg, as well as how naturally occurring T-reg cells might cooperate to promote and regulate autoimmune inflammation of the central nervous system (CNS). The monitoring of the population dynamics of these T cell subsets in reporter mice in vivo will enable us to revisit the pathogenic concept of autoimmune inflammation in the CNS and design rational and phase-specific therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17916388      PMCID: PMC2289998          DOI: 10.1016/j.jneuroim.2007.09.009

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  97 in total

Review 1.  A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3.

Authors:  Jason D Fontenot; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2005-04       Impact factor: 25.606

Review 2.  New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions.

Authors:  Christopher A Hunter
Journal:  Nat Rev Immunol       Date:  2005-07       Impact factor: 53.106

3.  Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.

Authors:  Marije I Koenders; Jay K Kolls; Birgitte Oppers-Walgreen; Liduine van den Bersselaar; Leo A B Joosten; Jill R Schurr; Paul Schwarzenberger; Wim B van den Berg; Erik Lubberts
Journal:  Arthritis Rheum       Date:  2005-10

4.  How defects in central tolerance impinge on a deficiency in regulatory T cells.

Authors:  Zhibin Chen; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

5.  A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection.

Authors:  Isabelle Suffia; Stacie K Reckling; Gerson Salay; Yasmine Belkaid
Journal:  J Immunol       Date:  2005-05-01       Impact factor: 5.422

6.  Regulatory T cell lineage specification by the forkhead transcription factor foxp3.

Authors:  Jason D Fontenot; Jeffrey P Rasmussen; Luke M Williams; James L Dooley; Andrew G Farr; Alexander Y Rudensky
Journal:  Immunity       Date:  2005-03       Impact factor: 31.745

7.  TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells.

Authors:  Julien C Marie; John J Letterio; Marc Gavin; Alexander Y Rudensky
Journal:  J Exp Med       Date:  2005-04-04       Impact factor: 14.307

8.  Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia.

Authors:  Claudia R Ruprecht; Marco Gattorno; Francesca Ferlito; Andrea Gregorio; Alberto Martini; Antonio Lanzavecchia; Federica Sallusto
Journal:  J Exp Med       Date:  2005-06-06       Impact factor: 14.307

9.  Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor.

Authors:  Iris Lee; Liqing Wang; Andrew D Wells; Martin E Dorf; Engin Ozkaynak; Wayne W Hancock
Journal:  J Exp Med       Date:  2005-04-04       Impact factor: 14.307

10.  Developmental regulation of Foxp3 expression during ontogeny.

Authors:  Jason D Fontenot; James L Dooley; Andrew G Farr; Alexander Y Rudensky
Journal:  J Exp Med       Date:  2005-10-03       Impact factor: 14.307

View more
  38 in total

1.  Antigen-specific splenic CD4+ and CD8+ regulatory T cells generated via the eye, suppress experimental autoimmune encephalomyelitis either at the priming or at the effector phase.

Authors:  Sourojit Bhowmick; Robert B Clark; Stefan Brocke; Robert E Cone
Journal:  Int Immunol       Date:  2011-01-27       Impact factor: 4.823

2.  B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity.

Authors:  Martin S Weber; Thomas Prod'homme; Juan C Patarroyo; Nicolas Molnarfi; Tara Karnezis; Klaus Lehmann-Horn; Dimitry M Danilenko; Jeffrey Eastham-Anderson; Anthony J Slavin; Christopher Linington; Claude C A Bernard; Flavius Martin; Scott S Zamvil
Journal:  Ann Neurol       Date:  2010-09       Impact factor: 10.422

Review 3.  Sensing the microenvironment of the central nervous system: immune cells in the central nervous system and their pharmacological manipulation.

Authors:  Zsuzsanna Fabry; Heidi A Schreiber; Melissa G Harris; Matyas Sandor
Journal:  Curr Opin Pharmacol       Date:  2008-09-02       Impact factor: 5.547

Review 4.  Hyaluronan in immune dysregulation and autoimmune diseases.

Authors:  Nadine Nagy; Hedwich F Kuipers; Payton L Marshall; Esther Wang; Gernot Kaber; Paul L Bollyky
Journal:  Matrix Biol       Date:  2018-04-04       Impact factor: 11.583

5.  Notch ligand delta-like 4 blockade alleviates experimental autoimmune encephalomyelitis by promoting regulatory T cell development.

Authors:  Ribal Bassil; Bing Zhu; Youmna Lahoud; Leonardo V Riella; Hideo Yagita; Wassim Elyaman; Samia J Khoury
Journal:  J Immunol       Date:  2011-08-03       Impact factor: 5.422

6.  Inhibition of microRNA-155 ameliorates experimental autoimmune myocarditis by modulating Th17/Treg immune response.

Authors:  Lianhua Yan; Fen Hu; Xiaofei Yan; Yuzhen Wei; Wenhan Ma; Ya Wang; Shuai Lu; Zhaohui Wang
Journal:  J Mol Med (Berl)       Date:  2016-04-06       Impact factor: 4.599

7.  IL-9 Controls Central Nervous System Autoimmunity by Suppressing GM-CSF Production.

Authors:  Satoshi Yoshimura; Rodolfo Thome; Shingo Konno; Elisabeth R Mari; Javad Rasouli; Daniel Hwang; Alexandra Boehm; Yanhua Li; Guang-Xian Zhang; Bogoljub Ciric; Abdolmohamad Rostami
Journal:  J Immunol       Date:  2019-12-18       Impact factor: 5.422

8.  Brain protection conferred by long-term administration of 2-(2-benzofuranyl)-2-imidazoline against experimental autoimmune encephalomyelitis.

Authors:  Ying-Biao Zhu; Nian-Ge Xia; Yuan-Tao Zhang; Xin-Shi Wang; Shan-Shan Liang; Wei-Yong Yin; Hui-Qin Xu; Sheng-Tao Hou; Rong-Yuan Zheng
Journal:  Neurochem Res       Date:  2014-12-19       Impact factor: 3.996

9.  Deficiency of thrombospondin-1 reduces Th17 differentiation and attenuates experimental autoimmune encephalomyelitis.

Authors:  Kaiyong Yang; Jose L Vega; Muhamed Hadzipasic; Jean Pierre Schatzmann Peron; Bing Zhu; Yijun Carrier; Sharmila Masli; Luiz Vicente Rizzo; Howard L Weiner
Journal:  J Autoimmun       Date:  2009-02-01       Impact factor: 7.094

10.  Feedback control of regulatory T cell homeostasis by dendritic cells in vivo.

Authors:  Guillaume Darrasse-Jèze; Stephanie Deroubaix; Hugo Mouquet; Gabriel D Victora; Thomas Eisenreich; Kai-hui Yao; Revati F Masilamani; Michael L Dustin; Alexander Rudensky; Kang Liu; Michel C Nussenzweig
Journal:  J Exp Med       Date:  2009-08-10       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.